tiprankstipranks
Kairos Pharma, Ltd. (KAPA)
:KAPA
US Market
KAPA
Kairos Pharma, Ltd.
RESEARCH TOOLSreports

Kairos Pharma, Ltd. (KAPA) Stock Forecast & Price Target

Compare
46 Followers
See the Price Targets and Ratings of:

KAPA Financial Forecast

No data currently available

KAPA Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.
No data currently available

KAPA Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
D. Boral Capital
$9
Buy
552.17%
Upside
Initiated
10/14/24
Kairos Pharma initiated with a Buy at EF HuttonKairos Pharma initiated with a Buy at EF Hutton
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Kairos Pharma, Ltd.

Which Analyst Should I Follow If I Want to Buy KAPA and Sell After:
1 Month
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+35.10%
initiated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +35.10% per trade.
3 Months
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-0.60%
initiated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -0.60% per trade.
1 Year
Jason KolbertD. Boral Capital
Success Rate
0/1 ratings generated profit
0%
Average Return
-9.20%
initiated a buy rating 4 months ago
Copying Jason Kolbert's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -9.20% per trade.
2 Years
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-9.20%
initiated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -9.20% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

KAPA Analyst Recommendation Trends

Rating
Oct 24
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
total
1
In the current month, KAPA has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. KAPA average Analyst price target in the past 3 months is $9.00.
Each month's total comprises the sum of three months' worth of ratings.

KAPA Stock Forecast FAQ

What is KAPA’s average 12-month price target, according to analysts?
Based on analyst ratings, Kairos Pharma, Ltd.’s 12-month average price target is $9.00.
    What is KAPA’s upside potential, based on the analysts’ average price target?
    Kairos Pharma, Ltd. has 552.17% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is KAPA a Buy, Sell or Hold?
          Kairos Pharma, Ltd. has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Kairos Pharma, Ltd.’s price target?
            The average price target for Kairos Pharma, Ltd. is $9.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $9.00 ,the lowest forecast is $9.00. The average price target represents 552.17% Increase from the current price of $1.38.
              What do analysts say about Kairos Pharma, Ltd.?
              Kairos Pharma, Ltd.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of KAPA?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis